ESMO Clinical Practice Guidelines: Endocrine and Neuroendocrine Cancers

Latest enhanced and revised set of guidelines

ESMO has two Clinical Practice Guidelines on Neuroendocrine Tumours: Neuroendocrine bronchial and thymic tumours and Neuroendocrine gastroenteropancreatic tumours.  They include information on incidence, diagnosis, staging and risk assessment, treatment, response evaluation and follow-up.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings